Welcome to our dedicated page for Under Armour SEC filings (Ticker: UAA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Under Armour's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Under Armour's regulatory disclosures and financial reporting.
Under Armour, Inc. director Dawn N. Fitzpatrick received an equity grant of 4,910.71 shares of Class C Common Stock as part of her board compensation. The shares were issued as deferred stock units under the Under Armour, Inc. Fiscal Year 2025 Non-Employee Director Compensation Plan and carried no cash exercise price. Following this award, she directly holds a total of 180,340.67 Class C shares.
Under Armour director Carolyn Everson acquired additional equity-based compensation through deferred stock units. On April 1, 2026, she received 892.86 shares of Class C Common Stock at $0.00 per share as director fees deferred under the company’s Fiscal Year 2025 Non-Employee Director Compensation Plan. Following this grant, she directly holds 108,431.14 Class C shares, reflecting routine non-employee director compensation rather than an open-market purchase or sale.
El-Erian Mohamed reported acquisition or exercise transactions in this Form 4 filing.
Under Armour, Inc. director Mohamed El-Erian received a grant of 11,830.36 shares of Class C Common Stock as deferred stock units. The grant represents director fees deferred under the Under Armour, Inc. Fiscal Year 2025 Non-Employee Director Compensation Plan.
After this award, he holds 224,011.67 shares of Class C Common Stock and 111,650 shares of Class A Common Stock directly. This transaction reflects compensation in stock units rather than an open-market purchase or sale.
Under Armour, Inc. director Douglas E. Coltharp reported an equity award of Class C Common Stock deferred stock units. On April 1, 2026, he received 6,361.6100 Class C shares at a stated price of $0.00 per share, representing director fees deferred under the company’s Fiscal Year 2025 Non-Employee Director Compensation Plan.
After this grant, Coltharp holds 317,690.4700 Class C shares directly, along with additional direct and indirect holdings of both Class C and Class A shares through personal accounts and family trusts. The filing reflects a compensation-related acquisition rather than an open-market trade.
The Vanguard Group filed Amendment No. 12 to Schedule 13G/A reporting zero beneficial ownership of Under Armour Inc. common stock as of the amendment. The filing explains an internal realignment effective January 12, 2026, under SEC Release No. 34-39538, after which certain Vanguard subsidiaries report ownership separately and Vanguard no longer is deemed to beneficially own those securities.
The form lists 0 shares beneficially owned, 0% of the class, and zero voting and dispositive power. The filing is signed by Ashley Grim, Head of Global Fund Administration, dated 03/27/2026.
Under Armour, Inc. Form 144 notice reports proposed sales of multiple lots of Class A and Class C common stock that were acquired as restricted stock units. The filing lists individual lots with acquisition dates from 02/15/2015 through 02/15/2021
Under Armour, Inc. Chief Accounting Officer Eric J. Aumen reported a tax-related share disposition under the company’s equity plans. On February 15, 2026, 2,376 shares of Class C Common Stock were disposed of to cover tax withholding obligations, at a reported price of $0.00 per share.
After this transaction, Aumen directly owned about 90,701.5626 Class C shares, which includes shares acquired through Under Armour’s Employee Stock Purchase Plan. The filing reflects an administrative tax-withholding event rather than an open-market purchase or sale.
Taleghani Reza reported acquisition or exercise transactions in this Form 4 filing.
Under Armour, Inc. reported that Chief Financial Officer Reza Taleghani was granted 1,069,520 Employee Stock Options (Right to Buy) on February 13, 2026. According to the filing, these options become exercisable in three equal installments beginning February 15, 2027. The report also shows he directly holds 68,965 shares of Class A Common Stock following the reported transactions.
Trent Kara reported acquisition or exercise transactions in this Form 4 filing.
Under Armour, Inc. Chief Merchandising Officer Kara Trent reported an equity award of 35,869 shares of Class C Common Stock on 2026-02-13. The shares were granted at a price of $0.0000 per share as a stock award, rather than an open-market purchase. Following this grant, Trent directly holds 459,742 Class C shares, aligning her compensation more closely with the company’s future performance.
Under Armour, Inc. President of the Americas Adam Peake reported an acquisition of Class C Common Stock through an equity grant. He received 50,216 Class C shares at a reported price of $0.0000 per share, bringing his Class C holdings to 127,669 shares directly owned.
The filing also shows he directly holds 33,200 shares of Class A Common Stock following the reported transactions.